Search results

Articles (6)

Journals (0)

1-6 of 6 results for zilucoplan

Sort by:

Relevance

Select all

Sort by:

Relevance

Open accessResearch articleFirst published 2026

Real-world effectiveness and safety of zilucoplan in patients with anti-AChR myasthenia gravis: A retrospective cohort study in France

Giulia Tammam, Abderhmane Slioui, Diane Friedman [...]

Journal of Neuromuscular Diseases

Open accessResearch articleFirst published 2024

Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study

James F. Howard, Saskia Bresch, Constantine Farmakidis [...]

Therapeutic Advances in Neurological Disorders

Open accessResearch articleFirst published 2025

Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in generalised myasthenia gravis: a phase IIIb,open-label study

Miriam Freimer, Urvi Desai, Raghav Govindarajan [...]

Therapeutic Advances in Neurological Disorders

Open accessResearch articleFirst published 2024

Maintenance of zilucoplan efficacy in patients with generalised myasthenia gravis up to 24 weeks: a model-informed analysis

Guillemette de la Borderie, Damien Chimits, Babak Boroojerdi [...]

Therapeutic Advances in Neurological Disorders

Open accessReview articleFirst published 2026

Meningococcal prophylaxis in neurological diseases treated with complement inhibitors: an expert consensus for Germany,Austria,and Switzerland

Achim Berthele, Orhan Aktas, Ilya Ayzenberg [...]

Therapeutic Advances in Neurological Disorders

Open accessResearch articleFirst published 2025

Cellular and humoral vaccination response under immunotherapies—German consensus on vaccination strategies in neurological autoimmune diseases

Muriel Schraad, Mathias Mäurer, Anke Salmen [...]

Therapeutic Advances in Neurological Disorders

Search results

Articles (6)

Journals (0)

1-6 of 6 results for zilucoplan

Sort by:

Relevance

Select all

Sort by:

Relevance

Open accessResearch articleFirst published 2026

Real-world effectiveness and safety of zilucoplan in patients with anti-AChR myasthenia gravis: A retrospective cohort study in France

Giulia Tammam, Abderhmane Slioui, Diane Friedman [...]

Journal of Neuromuscular Diseases

Open accessResearch articleFirst published 2024

Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study

James F. Howard, Saskia Bresch, Constantine Farmakidis [...]

Therapeutic Advances in Neurological Disorders

Open accessResearch articleFirst published 2025

Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in generalised myasthenia gravis: a phase IIIb,open-label study

Miriam Freimer, Urvi Desai, Raghav Govindarajan [...]

Therapeutic Advances in Neurological Disorders

Open accessResearch articleFirst published 2024

Maintenance of zilucoplan efficacy in patients with generalised myasthenia gravis up to 24 weeks: a model-informed analysis

Guillemette de la Borderie, Damien Chimits, Babak Boroojerdi [...]

Therapeutic Advances in Neurological Disorders

Open accessReview articleFirst published 2026

Meningococcal prophylaxis in neurological diseases treated with complement inhibitors: an expert consensus for Germany,Austria,and Switzerland

Achim Berthele, Orhan Aktas, Ilya Ayzenberg [...]

Therapeutic Advances in Neurological Disorders

Open accessResearch articleFirst published 2025

Cellular and humoral vaccination response under immunotherapies—German consensus on vaccination strategies in neurological autoimmune diseases

Muriel Schraad, Mathias Mäurer, Anke Salmen [...]

Therapeutic Advances in Neurological Disorders